Preventing fetal damage from sexually transmitted diseases.

Area of Science:

• Reproductive Health
• Infectious Diseases
• Maternal-Fetal Medicine

Background:

• Sexually transmitted diseases (STDs) present a substantial threat to women's reproductive health, leading to adverse outcomes such as premature birth, congenital infections, and mortality.
• These infections can cause significant perinatal damage, impacting both the mother and the developing fetus.

Purpose of the Study:

• To emphasize the importance of understanding the natural history of STDs for effective intervention.
• To highlight primary prevention strategies, including safer sex practices, for reducing maternal and infant morbidity.
• To discuss current therapeutic limitations and recommendations for managing specific STDs during pregnancy.

Main Methods:

• Review of current literature on the impact of STDs on reproductive health.
• Analysis of the natural progression of common STDs in pregnant women.
• Evaluation of existing and potential therapeutic interventions for STDs in pregnancy.

Main Results:

• Primary prevention through safer sex practices is crucial for reducing STD transmission and associated health risks.
• Antiviral therapies are currently unavailable for human papillomavirus (HPV), herpes simplex virus (HSV), human immunodeficiency virus (HIV), and hepatitis B virus (HBV) infections during pregnancy.
• Early antibiotic treatment can effectively reduce the risks of congenital syphilis, chlamydial, and gonococcal infections in newborns.

Conclusions:

• Understanding STD natural history is key to mitigating perinatal damage and improving reproductive health outcomes.
• Safer sex practices are paramount for primary prevention in sexually active women.
• Timely antibiotic therapy is vital for managing bacterial STDs, while viral STDs require further research for effective fetal protection strategies.